Uncertainty Looms After Hexo Reports Decent Earnings

Here’s why investors seem to be hesitant with Hexo (TSX:HEXO)(NYSE:HEXO) right now.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Hexo (TSX:HEXO)(NYSE:HEXO) is a company I think remains a great play on the domestic Canadian cannabis market. Hexo’s recently reported decent earnings, and investors may be excited about its existing business.

However, its recent acquisitions paint a different picture.

It now appears this company is trying to push to become a global player. As it is currently still a relatively small player in the global cannabis space, this is a good thing. There’s a race to the top, and Hexo seems willing to look at expanding in prudent ways.

That said, this space is a volatile one. Accordingly, it appears some investors feel there’s too much uncertainty with this stock right now.

Hexo’s decent earnings call is worth a second look

Hexo’s recent earnings certainly provide investors with what looks like pretty decent long-term upside. The company reported total net revenue of $32.9 million this past quarter. This was up from $17 million from the prior-year quarter.

That’s some decent revenue growth.

Additionally, this past quarter marked the seventh consecutive quarter where the firm reported positive adjusted EBITDA. Not only that, but the firm also noted that non-beverage adult-use revenue increase by 6% amid growing beverage-based adult-use sales.

Net revenue of adult-use cannabis products also marked the fifth consecutive quarter of improvement. This has helped Hexo to maintain the lead market share position in Quebec’s cannabis market. Revenue for the rest of Canada increased by 49%, signaling the company isn’t just a tiny regional player any more.

These earnings are a testament to this company’s long-term potential. Indeed, investors will continue to be looking at the company’s high-margin products to see how profitable Hexo will be long term.

Foreign growth a key for investors

While the earnings call paints a promising picture, investors seem to be worried about the company’s global expansion potential. Hexo still isn’t a company with direct access to the U.S. market like other Canadian-listed peers. Additionally, despite impressive revenue growth, this firm’s financial position leaves something more to desire.

As of a month ago, Hexo had no real presence in the U.S. market. The firm has heavily focused on improving its foothold in the domestic market and is just starting to build its foreign brand strategy.

Hexo has placed its bets on Charles Bowman, who was recently inducted as the general manager of U.S. operations, and Rose Marie Gage, chair of director board. They are supposed to contribute with their extensive experience in operations to improve Hexo’s market presence in the U.S.

However, until more progress is made, many investors may continue to sit on the sidelines.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »